Mark W. Hahn serves as Executive at Dova Pharmaceuticals Inc., where they oversee executive responsibilities. Since joining the company, Mark W. Hahn has executed 52 insider transactions totaling $12.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 4, 2019 involved receiving (via award) 8,844 shares valued at $0.
Mark W. Hahn currently holds 10,046 shares of Dova Pharmaceuticals Inc. (DOVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark W. Hahn has been a net seller of DOVA stock. They have purchased $15.7K and sold $12.1M worth of shares.
Mark W. Hahn's most recent insider trade was on Jan 4, 2019, when they sold 8,844 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.28 |
| Discretionary |